MPT Q2 2026: Revenue Gains and Refinancing Tempered by Impairments and Rising Interest Costs
MPT is trading near its 52-week low of $3.95 (6.3% above the low) on elevated volume (4.7× avg).
Summary
MPT's Q2 2026 featured revenue growth from re-tenanted assets but a net loss, with a $2.4B refinancing and asset sales providing liquidity against a backdrop of high leverage and tenant credit challenges.
Key Events · Earnings and Guidance · MPT
-
Q2 Revenue Up, Net Loss Narrowed
Total revenues rose 7.9% to $259.3M, driven by $16.4M more lease revenue from re-tenanted Steward/Prospect facilities. Net loss attributable to common stockholders was $2.6M ($0.01/share), a significant improvement from the $98.4M loss in Q2 2025.
-
Normalized FFO Beats Prior Year
Normalized FFO was $92.2M ($0.15/share) vs. $81.4M ($0.14/share) in Q2 2025, reflecting higher cash rents and lower non-cash fair value adjustments.
-
$16.8M in Impairment Charges
Real estate and other impairment charges of $16.8M were primarily from further write-downs of working capital loans to Insight and Tenor, highlighting ongoing tenant credit issues.
-
$2.4B Refinancing at 9.25% After Quarter-End
On August 10, 2026, MPT agreed to issue $2.4B in new secured notes at 9.25% due 2032, using proceeds to pay off near-term maturities and extend debt profile, capturing a $123M discount.
Analysis · MPT · Real Estate & Construction
Medical Properties Trust delivered a mixed second quarter. While revenue climbed 7.9% year-over-year to $259.3 million—fueled by the ramp-up of re-tenanted Steward and Prospect facilities—the company still posted a net loss of $2.6 million. On a per-share basis, normalized FFO of $0.15 edged past the prior year's $0.14. The quarter carried $16.8 million in impairment charges, largely tied to loans to Insight and Tenor, and interest expense rose to $135.3 million. The balance sheet remains highly leveraged with $9.7 billion in debt, but a $2.4 billion refinancing at 9.25% announced after quarter-end extends maturities to 2032 and eases near-term pressure. Additional liquidity came from the Infracore IPO and the sale of the Utah partnership. Although the refinancing buys time, the high coupon and persistent tenant credit issues keep risk elevated.
At the time of this filing, MPT was trading at $4.20 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $3.95 to $6.47. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.